617 filings
Page 10 of 31
8-K
2iza82p1wcj iy8rpe
22 Jun 20
VBI Vaccines Announces Results of Annual General Meeting
12:45pm
8-K
uoknov 2zg
22 Jun 20
Regulation FD Disclosure
8:46am
8-K
hlydl
17 Jun 20
VBI Vaccines to Present at Upcoming Investor Conferences
8:54am
8-K
a57j9j34xzduk4h5f
29 May 20
VBI Vaccines Announces Formation of Commercial Advisory Board
3:23pm
8-K
dnmw qv5w
27 May 20
VBI Vaccines Secures $50 Million Debt Financing From K2 HealthVentures
5:15pm
D
zla6ijm
27 May 20
$4.7M in equity / options / securities to be acquired, sold $4.7M, 1 investor
4:15pm
8-K
4kueq msw
15 May 20
VBI Vaccines Announces Upcoming Poster Presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR Virtual Annual Meeting
12:39pm
8-K
kk4v80xl19mo969vi
6 May 20
Results of Operations and Financial Condition
8:35am
D
vohms8ls g2q3q
1 May 20
$1.06M in options / securities to be acquired, sold $1.06M, 61 investors
12:00am
DEFA14A
8ox8hdknq0vbn04h
28 Apr 20
Additional proxy soliciting materials
4:10pm
8-K
hxlb9
27 Apr 20
VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:52am
8-K
qq12hkqs5j5dn00m6
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
424B5
028tstfi7j1opx yq
24 Apr 20
Prospectus supplement for primary offering
6:11am
424B5
ppb98349 t8j
21 Apr 20
Prospectus supplement for primary offering
4:18pm
8-K
f02h5d c0vxtehfw46bd
31 Mar 20
VBI Vaccines Announces Collaboration with the National Research Council of
8:14am
8-K
wlagk
13 Mar 20
VBI Vaccines Appoints Damian Braga to Board of Directors
12:59pm
8-K
pxlytyxl7 am1rpi
5 Mar 20
VBI Vaccines Provides Corporate Update, Outlook for 2020, and Year-End 2019 Financial Results
12:40pm